These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7939573)

  • 41. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
    Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
    Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant melanoma: Mayo Clinic experience.
    Sim FH; Nelson TE; Pritchard DJ
    Mayo Clin Proc; 1997 Jun; 72(6):565-9. PubMed ID: 9179142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
    Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
    Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous melanoma: detecting it earlier, weighing management options.
    Lane JE; Dalton RR; Sangueza OP
    J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
    [No Abstract]   [Full Text] [Related]  

  • 48. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
    Richtig E; Ludwig R; Kerl H; Smolle J
    Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
    Denisov LE; Kurdina MI
    Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of unfavorable presentation of primary cutaneous melanoma.
    Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
    J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
    [No Abstract]   [Full Text] [Related]  

  • 52. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].
    Hauschild A; Dummer R; Garbe C; Kaufmann R; Schadendorf D; Soyer HP; Stadler R; Tilgen W
    Hautarzt; 1998 Mar; 49(3):167-9. PubMed ID: 9565782
    [No Abstract]   [Full Text] [Related]  

  • 55. Malignant melanoma occurring during pregnancy: a report of the Northern Israel Oncology Center (1968-1988).
    Stein M; Fried G; Borovik R; Halpern J; Beck D; Robinson E
    J Surg Oncol; 1990 Oct; 45(2):117-20. PubMed ID: 2214789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nowadays a histological sub-typing of thin melanoma is demanded for a proper patient management.
    Piscioli F; Pusiol T; Roncati L
    J Plast Reconstr Aesthet Surg; 2016 Nov; 69(11):1563-1564. PubMed ID: 27639421
    [No Abstract]   [Full Text] [Related]  

  • 57. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
    Claeson M; Gillstedt M; Whiteman DC; Paoli J
    Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of Early-Stage Melanoma.
    Quintanilla-Dieck MJ; Bichakjian CK
    Facial Plast Surg Clin North Am; 2019 Feb; 27(1):35-42. PubMed ID: 30420071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent Changes and Innovations in Melanoma Treatment: A Review.
    Sabag N; Yakobson A; Silberstein E
    Isr Med Assoc J; 2020 Nov; 11(22):704-710. PubMed ID: 33249792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Desmoplastic neurotropic melanoma.
    Tsao H; Sober AJ; Barnhill RL
    Semin Cutan Med Surg; 1997 Jun; 16(2):131-6. PubMed ID: 9220552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.